We are live on ! Find out more
BRM

Boston Research & Management Portfolio holdings

AUM $421M
1-Year Est. Return 16.18%
This Fund
S&P 500
This Quarter Est. Return
+7.29%
1 Year Est. Return
+16.18%
3 Year Est. Return
+48.21%
5 Year Est. Return
+65.09%
10 Year Est. Return
+242.1%
AUM
$199M
AUM Growth
+$3.73M
Cap. Flow
-$8.84M
Cap. Flow %
-4.43%
Top 10 Hldgs %
24.27%
Holding
98
New
2
Increased
5
Reduced
64
Closed
1

Top Buys

Rank Stock Value
1
IVV icon
iShares Core S&P 500 ETF
IVV
+$582K
2
IBB icon
iShares Biotechnology ETF
IBB
+$530K
3
TXN icon
Texas Instruments
TXN
+$201K
4
VZ icon
Verizon
VZ
+$93.4K
5
IJR icon
iShares Core S&P Small-Cap ETF
IJR
+$34.5K

Top Sells

Rank Stock Value
1
BBH icon
VanEck Biotech ETF
BBH
+$623K
2
IWM icon
iShares Russell 2000 ETF
IWM
+$600K
3
GE icon
GE Aerospace
GE
+$573K
4
MSFT icon
Microsoft
MSFT
+$445K
5
XLE icon
State Street Energy Select Sector SPDR ETF
XLE
+$433K

Sector Composition

Rank Sector Weight
1 Industrials 14.54%
2 Technology 13.69%
3 Financials 12.39%
4 Healthcare 11.03%
5 Consumer Staples 10.05%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ORCL icon
76
Oracle
ORCL
$345B
$449K 0.23%
9,510
– –
PPG icon
77
PPG Industries
PPG
$26.4B
$432K 0.22%
3,700
– –
ITW icon
78
Illinois Tool Works
ITW
$81.9B
$430K 0.22%
2,580
– –
LLY icon
79
Eli Lilly
LLY
$1.07T
$406K 0.2%
4,815
– –
EMR icon
80
Emerson Electric
EMR
$83.6B
$402K 0.2%
5,780
– –
AMLP icon
81
Alerian MLP ETF
AMLP
$12.7B
$399K 0.2%
7,405
-450
-6% -$24.1K
YUM icon
82
Yum! Brands
YUM
$40.7B
$364K 0.18%
4,468
– –
DD icon
83
DuPont de Nemours
DD
$18.9B
$363K 0.18%
2,015
– –
UNP icon
84
Union Pacific
UNP
$178B
$351K 0.18%
2,620
– –
WM icon
85
Waste Management
WM
$95.5B
$308K 0.15%
3,580
-110
-3% -$8.96K
MRK icon
86
Merck
MRK
$323B
$286K 0.14%
5,337
-2,442
-31% -$135K
MNDT
87
DELISTED
Mandiant, Inc. Common Stock
MNDT
$268K 0.13%
18,900
– –
VFC icon
88
VF Corp
VFC
$6.72B
$256K 0.13%
3,675
– –
CLX icon
89
Clorox
CLX
$11.8B
$237K 0.12%
1,595
– –
EFA icon
90
iShares MSCI EAFE ETF
EFA
$76.8B
$231K 0.12%
3,286
– –
SO icon
91
Southern Company
SO
$109B
$228K 0.11%
4,750
– –
GPC icon
92
Genuine Parts
GPC
$17.6B
$227K 0.11%
2,390
– –
DHR icon
93
Danaher
DHR
$138B
$224K 0.11%
2,726
– –
OXY icon
94
Occidental Petroleum
OXY
$54.6B
$219K 0.11%
2,980
-580
-16% -$39.4K
TXN icon
95
Texas Instruments
TXN
$255B
$215K 0.11%
+2,060
New +$201K
MRSH
96
Marsh
MRSH
$87.5B
$213K 0.11%
2,620
-200
-7% -$16.6K
AMGN icon
97
Amgen
AMGN
$203B
$205K 0.1%
1,180
– –
XLE icon
98
State Street Energy Select Sector SPDR ETF
XLE
$38.8B
– –
-12,660
Closed -$433K
1 2 3
4

Similar funds

SCV
Sands Capital Ventures Arlington, Virginia $421M AUM 26.25% 1-Year Est. Return
TFP
Triune Financial Partners Overland Park, Kansas $421M AUM 22.09% 1-Year Est. Return
CWM
Cordatus Wealth Management Newtown, Pennsylvania $420M AUM 24.63% 1-Year Est. Return
MG
MilWealth Group Milwaukee, Wisconsin $420M AUM 12.37% 1-Year Est. Return
HWMG
Hurlow Wealth Management Group Bloomington, Indiana $420M AUM 16.85% 1-Year Est. Return
AI
ArchPoint Investors Coral Gables, Florida $420M AUM 42.19% 1-Year Est. Return
LSWM
Lorne Steinberg Wealth Management Montreal, Quebec, Canada $422M AUM 23.86% 1-Year Est. Return
IMA
Investment Management Associates Greenwood Village, Colorado $420M AUM 11.81% 1-Year Est. Return

Boston Research & Management's Q4 2017 Portfolio in Review

As of Q4 2017, Boston Research & Management held 98 positions worth $199M, up 1.9% from $196M the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Boston Research & Management withdrew a net $8.84M in Q4 2017, closing 1 position and reducing 64 holdings. Its most notable exit was State Street Energy Select Sector SPDR ETF, an estimated $433K position sold in full.

By sector, the portfolio is most concentrated in Industrials at 15% of assets, down from 15% a quarter earlier, followed by Technology and Financials.

Against the trend, Boston Research & Management opened a new position in iShares Biotechnology ETF worth $529K.

  • Boston Research & Management's largest Q4 2017 buy was iShares Biotechnology ETF: 4,959 shares worth $529K.
  • Boston Research & Management added most to iShares Core S&P 500 ETF in Q4 2017, an estimated $582K increase.
  • Boston Research & Management's biggest Q4 2017 reduction was VanEck Biotech ETF, cutting an estimated $623K.
  • Boston Research & Management fully exited State Street Energy Select Sector SPDR ETF in Q4 2017, selling an estimated $433K.
  • Boston Research & Management's ten largest holdings make up 24% of its $199M portfolio in Q4 2017.
  • Boston Research & Management opened 2 new positions and closed 1 in Q4 2017.
  • Boston Research & Management's portfolio value rose 1.9% quarter-over-quarter to $199M.

Based on Boston Research & Management's 13F filing for Q4 2017, filed 9 Feb 2018.